All Type of News
AstraZeneca was domestically approved for the atomized-type product of its asthma treatment ‘Symbicort’
The new formulation of the AstraZeneca’s asthma treatment, Symbicort, is about to be launched. Its strength is the easier inhalation with the atomized type than the existing products.
According to the Ministry of Foo...
Who will be the winner in the new drug challenge of the KRW 2.6 trillion xerophthalmia market?
Aim for the xerophthalmia market. Domestic pharmaceutical companies have made challenges to new xerophthalmia drugs in the global market.
Although no product has been commercialized, products of the pharmaceutical co...
BMS Korea and its labor union successfully concluded the wage negotiation
BMS Korea (CEO Eun-young Kim) has recently concluded the wage negotiation by signing the 2015 final collective bargaining and wage increase agreement, participated by CEO Eun-young Kim, the union head, Dae-hee Yoo, an...
Lilly has been approved for the obesity-control diabetes drub ‘Trulicity’ in the domestic market
It is observed that Lilly Korea will launch the new diabetes treatment with the GLP-1 analogue type.
The drug type is the obesity-control diabetes drug, which has been highly interested by the current market.
The ty...
Galderma gava a priot notice to adopt a gel-type facial flushing treatment in the Korean market
A spreading-type facial flushing treatment is expected to be adopted in the Korean market.
According to the industry concerned on the 29th, Galderma has been working on a procedure to acquire a domestic approval of i...
Multinational pharmaceutical companies, such as MSD, Pfizer, Roche and AZ, are about to compete over immune antibodies
As domestic Phase 3 clinical trials have actively been made for immune antibodies indicated as the new cancer treatment, a new heated competition is expected in the antibody market.
While MSD and Ono have acquired ap...
Approximately 150 domestic and foreign influential pharmaceutical companies will gather in Seoul this September
‘CPhl Korea’ co-hosted by a global exhibition company, UBM, and the Korea Pharmaceutical Traders Associatio(KPTA) will take place at COEX, Seoul from the 7th to 9th of the coming September.
‘CPhl Korea 2014,’ held on...
The international pharmaceutical market will be expanded to $1.3 trillion in 2018
It is anticipated that the international pharmaceutical market will be increased to $1.3 trillion by 2018.
At the ‘GloPharmEx’ inauguration ceremony held at Intercontinental Hotel, COEX on the 27th, President Kyung-w...
Implications for the industry to learn as a half of the global top 10 drugs are specialty drugs
It has been noticed that the trend of the global new drug development is analyzed to certainly move from traditional drugs to specialty drugs, such as antibodies.
According to the recent report published by Yuanta Se...
Private and public organizations joined hands for pharmaceutical exportation, founding GloPharmEx
The Ministry of Food and Drug Safety, the Korea Pharmaceutical Traders Association (KPTA) and domestic pharmaceutical companies are rolling up their sleeves to export domestic pharmaceutical products.
At Intercontine...
